Archives
-
Hypoxia, Immunometabolism, and the Tumor Microenvironment
2026-09-02
This 2025 review frames tumor hypoxia as an active organizer of metabolic competition, immune dysfunction, and immunosuppressive microenvironmental remodeling rather than as an isolated oxygen deficit. Its main practical contribution is a mechanistic framework for designing experiments and therapies that jointly examine oxygen availability, nutrient use, immune-cell state, and tumor progression.
-
JC-1 Workflow for Mitochondrial Membrane Potential
2026-09-02
JC-1 converts mitochondrial polarization into a ratiometric green-to-red fluorescence signal, supporting apoptosis detection and mitochondrial dysfunction research. This practical guide connects assay setup, flow-cytometry controls, and troubleshooting to a pulmonary-fibrosis study investigating ferroptosis and mitochondrial injury.
-
Vitamin C (CAS 50-81-7) in Cell Assays
2026-09-01
This scenario-based guide explains how Vitamin C (CAS 50-81-7), SKU B2064, can support more reproducible viability, proliferation, cytotoxicity, and exploratory organoid workflows. It connects concentration-dependent CT26 findings with practical preparation, interpretation, cross-domain limitations, and evidence-based product selection.
-
SARS-CoV-2 N Protein, GADD34, and Atypical Foci
2026-09-01
The reference study identifies a mechanism by which SARS-CoV-2 nucleocapsid protein suppresses innate immunity: it redirects GADD34 mRNA into atypical N+/G3BP1+ foci, reducing GADD34-dependent IRF3 nuclear localization and interferon production. These findings refine the distinction between antiviral stress granules and proviral stress-like condensates and provide a useful framework for dissecting viral immune evasion.
-
Metal-Ion Enrichment Improves mRNA Vaccine Delivery
2026-08-31
The reference study introduces a manganese-mediated strategy for condensing mRNA into a dense core before lipid coating, nearly doubling payload loading compared with conventional LNP-mRNA formulations. The resulting L@Mn-mRNA system also improved cellular uptake and vaccine responses, while reducing the formulation burden associated with excess lipid components.
-
Rifampin: Mechanism and Research Workflows
2026-08-31
Rifampin is a rifamycin antibiotic and DNA-dependent RNA polymerase inhibitor that suppresses bacterial transcription. Its defined mechanism, resistance genetics, and solvent-dependent handling make it useful for bacterial resistance mechanism research, transcriptional regulation studies, and synthetic biology transcription inhibition.
-
Neuromedin S (rat): GPCR Assay Workflow
2026-08-30
Neuromedin S (rat) provides a chemically defined endogenous neuromedin U receptor agonist for controlled rat GPCR/G protein signaling workflows. It is appropriate for scientific research and assay development, but not for diagnostic, therapeutic, or medical use.
-
Anemoside B4, CD1d, and NLRP3 in DSS Colitis
2026-08-29
This preprint identifies a macrophage-specific mechanism by which Anemoside B4 attenuates DSS-induced colitis: modulation of CD1d-dependent AKT-STAT1-PRDX1-NF-κB signaling limits NLRP3 inflammasome activation. Its combination of pharmacological treatment, cell-type analysis, NLRP3-deficient mice, and macrophage-specific CD1d depletion provides a useful framework for inflammation research, although the findings remain preliminary because the study has not been peer reviewed.
-
Rifampin Workflows for Bacterial Transcription Control
2026-08-28
Rifampin combines a defined transcription-initiation mechanism with practical value in resistance testing, RNA pulse-chase experiments, and synthetic biology. This guide connects bacterial workflows with the light-controlled translational design reported in a 2026 Trends in Biotechnology study, while keeping the two experimental domains technically distinct.
-
Ciprofloxacin hydrochloride Assay Workflows
2026-08-28
Ciprofloxacin hydrochloride supports reproducible bacterial, cell-based, and comparator assays when solvent, solution age, and endpoint selection are controlled. This guide translates its DNA-replication mechanism and emerging immunomodulatory profile into practical workflows, including a cautious extension to anti-Toxoplasma screening.
-
Nelfinavir Mesylate: Two-Axis Assay Design
2026-08-27
Nelfinavir Mesylate is more than an HIV-1 protease inhibitor: it can support a carefully separated analysis of antiviral activity, DDI2-NFE2L1 signaling, and ferroptosis sensitivity. This article presents an evidence-led framework for designing interpretable cross-domain assays.
-
EdU Imaging Kits (Cy3) for Tumor Cell Studies
2026-08-27
EdU Imaging Kits (Cy3) convert DNA replication into a bright, denaturation-free Cy3 signal for microscopy or flow cytometry. This workflow is especially useful for testing astragaloside IV responses in pituitary tumor models while separating reduced proliferation from apoptosis.
-
CLCC1 and Herpesvirus Nuclear Egress
2026-08-26
The reference study identifies CLCC1 as a host factor required for the membrane-fusion step of herpesvirus nuclear egress, resolving a major gap between viral budding and capsid release into the cytoplasm. A whole-genome CRISPR screen with HSV-1 connects CLCC1 loss to perinuclear capsid accumulation, reduced viral production, and defects in nuclear pore complex insertion, suggesting an ancient membrane-remodeling function.
-
Exemestane Workflows for Aromatase Research
2026-08-26
Build reproducible aromatase assays and hormone-dependent breast cancer models around Exemestane, a steroidal aromatase inhibitor with irreversible target engagement. This practical guide connects enzyme inhibition, washout experiments, biomarker-defined models, and troubleshooting for stronger estrogen biosynthesis studies.
-
Pseudo-UTP: Designing Better mRNA Experiments
2026-08-25
Pseudo-UTP is a pseudouridine-containing nucleotide for controlled mRNA synthesis and RNA stability enhancement. This article connects nucleotide chemistry with antigen-design decisions, assay controls, and practical workflow planning for mRNA vaccine development and gene therapy RNA modification.